Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Lixte Biotechnology (NASDAQ:LIXT) through any online brokerage.
Other companies in Lixte Biotechnology’s space includes: Intensity Therapeutics Inc (NASDAQ:INTS), Lunai Bioworks Inc (NASDAQ:LNAI), Nanoviricides Inc (AMEX:NNVC), Barinthus Biotherapeutics PLC (NASDAQ:BRNS) and CollPlant Biotechnologies Ltd (NASDAQ:CLGN).
There is no analysis for Lixte Biotechnology to provide a consensus price target.
The stock price for Lixte Biotechnology (NASDAQ: LIXT) is $4.14 last updated December 15, 2025 at 9:30 AM EST.
There are no upcoming dividends for Lixte Biotechnology.
Lixte Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for Lixte Biotechnology.
Lixte Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.